Michael R. D’Agostino

Author

Also Known As

M. D'Agostino, M. R. D’Agostino, Marco D'Agostino, Michael D'Agostino, Michael D?Agostino, Michael D’Agostino, Michael R D’Agostino, Michael R D’agostino, Michael R. D'Agostino, Michael R. D’Agostino

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

McMaster University McMaster University Medical Centre University of British Columbia University of Waterloo Harvard University

About

Michael R. D’Agostino is an author at McMaster University specializing in medicine, vaccination, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	516
2	Immunology	4	4	499
3	Public Health	1	1	17
4	Allergy	1	1	149
5	Epidemiology	1	1	17

Michael R. D’Agostino

Publications

880

Citations

H-Index

Page 1

	Year	Citations
Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2 Sam Afkhami, Michael R. D’Agostino, Ali Zhang, Cell VaccinationVaccine SafetyMucosal VaccinationSpike ProteinVaccine Development	2022	312
Parenteral BCG vaccine induces lung-resident memory macrophages and trained immunity via the gut–lung axis Mangalakumari Jeyanathan, Maryam Vaseghi‐Shanjani, Sam Afkhami, Nature Immunology Trained ImmunityLung InflammationGut–lung AxisInnate Immune SystemImmunology	2022	149
Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses Arinjay Banerjee, Nader El-Sayes, Patrick Budylowski, iScience	2021	70
Gene-diet interactions and plasma lipoproteins: Role of apolipoprotein E and habitual saturated fat intake Hannia Campos, Michael R. D’Agostino, José M. Ordovás Genetic Epidemiology	2000	59
Airway Macrophages Mediate Mucosal Vaccine–Induced Trained Innate Immunity against <i>Mycobacterium tuberculosis</i> in Early Stages of Infection Michael R. D’Agostino, Rocky Lai, Sam Afkhami, The Journal of Immunology	2020	54
Mucosal-Pull Induction of Lung-Resident Memory CD8 T Cells in Parenteral TB Vaccine-Primed Hosts Requires Cognate Antigens and CD4 T Cells Siamak Haddadi, Maryam Vaseghi‐Shanjani, Yushi Yao, Frontiers in Immunology	2019	32
A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challenge Zachary R. Sia, Xuedan He, Ali Zhang, Proceedings of the National Academy of Sciences	2021	32
Robust Evaluation of Ultraviolet-C Sensitivity for SARS-CoV-2 and Surrogate Coronaviruses Scott Joseph Boegel, Merheb Gabriel, Michael Sasges, Microbiology Spectrum	2021	29
Differential Biodistribution of Adenoviral-Vectored Vaccine Following Intranasal and Endotracheal Deliveries Leads to Different Immune Outcomes Vidthiya Jeyanathan, Sam Afkhami, Michael R. D’Agostino, Frontiers in Immunology VaccinationVaccine SafetyDifferential BiodistributionMucosal VaccinationVaccine Development	2022	23
Intranasal multivalent adenoviral-vectored vaccine protects against replicating and dormant M.tb in conventional and humanized mice Sam Afkhami, Michael R. D’Agostino, Maryam Vaseghi‐Shanjani, npj Vaccines	2023	23

Page 1